Associated Papers
Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer.
Chen SH et al.
Cancer Medicine, 2024
38895905 (PubMed )
Supplement: CAM4-13-e7384-s003.xlsx › Sheet1
Molecular Divergence upon EGFR-TKI Resistance Could Be Dependent on the Exon Location of the Original EGFR-Sensitizing Mutation.
Serna-Blasco R et al.
Cancers, 2022
36139605 (PubMed )
Supplement: cancers-14-04446-s001.zip › Supplemental_data_S4.xlsx › variants_datasheet
Next-Generation Sequencing in Lung Cancer Patients: A Comparative Approach in NSCLC and SCLC Mutational Landscapes.
Pop-Bica C et al.
Journal of Personalized Medicine, 2022
35330454 (PubMed )
Supplement: jpm-12-00453-s001.zip › jpm-1596007-supplementary.xlsx › Tumor_tissue
Circulating tumour DNA sequencing to determine therapeutic response and identify tumour heterogeneity in patients with paediatric solid tumours.
Stankunaite R et al.
European Journal of Cancer (oxford, England : 1990), 2022
Gene symbol: UBE3A. Disease: Angelman syndrome.
Mueller OT et al.
Human Genetics, 2008
Gene symbol: UBE3A. Disease: Angelman syndrome.
Mueller OT et al.
Human Genetics, 2008
The spectrum of mutations in UBE3A causing Angelman syndrome.
Fang P et al.
Human Molecular Genetics, 1999
Select a paper to view details